Geode Capital Management, LLC Cogent Biosciences, Inc. Transaction History

Geode Capital Management, LLC

$1.24 Trillion
Q1 2025

A detailed history of Geode Capital Management, LLC transactions in Cogent Biosciences, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 2,415,854 shares of COGT stock, worth $17.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,415,854

Previous 2,308,509 4.65%

Holding current value

$17.1 Million

Previous $18 Million 19.64%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 13, 2025	BUY	$5.99 - $9.66 $642,996 - $1.04 Million	107,345 Added 4.65%	2,415,854 $14.5 Million
Q4 2024 Feb 12, 2025	BUY	$7.64 - $12.28 $211,750 - $340,352	27,716 Added 1.22%	2,308,509 $18 Million
Q3 2024 Nov 12, 2024	BUY	$8.24 - $11.48 $2.47 Million - $3.44 Million	300,062 Added 15.15%	2,280,793 $24.6 Million
Q2 2024 Aug 09, 2024	BUY	$6.01 - $9.04 $1.22 Million - $1.84 Million	203,627 Added 11.46%	1,980,731 $16.7 Million
Q1 2024 May 13, 2024	BUY	$4.38 - $9.02 $211,650 - $435,864	48,322 Added 2.8%	1,777,104 $11.9 Million
Q4 2023 Feb 13, 2024	BUY	$4.06 - $10.08 $331,036 - $821,882	81,536 Added 4.95%	1,728,782 $10.2 Million
Q3 2023 Nov 13, 2023	BUY	$9.69 - $13.34 $1.33 Million - $1.83 Million	136,952 Added 9.07%	1,647,246 $16.1 Million
Q2 2023 Aug 11, 2023	BUY	$9.85 - $13.24 $1.89 Million - $2.54 Million	191,986 Added 14.56%	1,510,294 $17.9 Million
Q1 2023 May 15, 2023	BUY	$10.04 - $15.5 $963,619 - $1.49 Million	95,978 Added 7.85%	1,318,308 $14.2 Million
Q4 2022 Feb 13, 2023	BUY	$10.65 - $14.84 $506,620 - $705,938	47,570 Added 4.05%	1,222,330 $14.1 Million
Q3 2022 Nov 14, 2022	BUY	$9.39 - $16.99 $4.1 Million - $7.42 Million	436,836 Added 59.2%	1,174,760 $17.5 Million
Q2 2022 Aug 12, 2022	BUY	$3.92 - $9.73 $553,747 - $1.37 Million	141,262 Added 23.68%	737,924 $6.66 Million
Q1 2022 May 13, 2022	BUY	$5.31 - $8.7 $97,135 - $159,149	18,293 Added 3.16%	596,662 $4.47 Million
Q4 2021 Feb 11, 2022	BUY	$7.51 - $10.81 $4,543 - $6,540	605 Added 0.1%	578,369 $4.96 Million
Q3 2021 Nov 12, 2021	BUY	$5.99 - $9.14 $23,331 - $35,600	3,895 Added 0.68%	577,764 $4.86 Million
Q2 2021 Aug 13, 2021	BUY	$7.82 - $9.3 $2.56 Million - $3.04 Million	326,825 Added 132.29%	573,869 $4.65 Million
Q1 2021 May 12, 2021	BUY	$7.47 - $12.34 $259,134 - $428,074	34,690 Added 16.34%	247,044 $2.17 Million
Q4 2020 Feb 12, 2021	BUY	$9.04 - $13.01 $1.92 Million - $2.76 Million	212,354 New	212,354 $2.38 Million

Others Institutions Holding COGT

# of Institutions

196

Shares Held

116M

Call Options Held

61.9K

Put Options Held

223K

View Full List

About Cogent Biosciences, Inc.

Ticker COGT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,758,300
Market Cap $466M
Description
Cogent Biosciences, Inc., a biotechnology company, focuses on developing precision therapies for genetically defined diseases. Its lead product candidate includes CGT9486, a selective tyrosine kinase inhibitor designed to inhibit the KIT D816V mutation that drives systemic mastocytosis, as well as other mutations in KIT exon 17, which are found ...

More about COGT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account

Geode Capital Management, LLC Cogent Biosciences, Inc. Transaction History